101 related articles for article (PubMed ID: 155781)
1. Growth hormone hyperresponsiveness to dopaminergic stimulation in Huntington's chorea.
Müller EE; Parati EA; Panerai AE; Cocchi D; Caraceni T
Neuroendocrinology; 1979; 28(5):313-9. PubMed ID: 155781
[TBL] [Abstract][Full Text] [Related]
2. Altered growth hormone and prolactin responses to dopaminergic stimulation in Huntington's chorea.
Caraceni T; Panerai AE; Paratl EA; Cocchi D; Müller EE
J Clin Endocrinol Metab; 1977 May; 44(5):870-5. PubMed ID: 140180
[TBL] [Abstract][Full Text] [Related]
3. [Huntington's chorea and somatotropic hormone: dynamic explorations in 27 cases (author's transl)].
Destée A; Petit H; Fossati P; Warot P
Rev Neurol (Paris); 1981; 137(1):21-31. PubMed ID: 6453416
[No Abstract] [Full Text] [Related]
4. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
Peillon F; Cesselin F; Bression D; Zygelman N; Brandi AM; Nousbaum A; Mauborgne A
J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
[TBL] [Abstract][Full Text] [Related]
5. Prolactin response as an index of dopaminergic receptor function in Parkinson's disease. Correlation with clinical findings and therapeutic response.
Agnoli A; Baldassarre M; Ruggieri S; Falaschi P; Urso RD; Rocco A
J Neural Transm; 1981; 51(1-2):123-34. PubMed ID: 7264625
[TBL] [Abstract][Full Text] [Related]
6. Hypothalamo-pituitary dopaminergic system in patients with myotonic dystrophy.
Sakuma H; Takase S; Mizuno Y; Teramura K; Hanew K
Tohoku J Exp Med; 1988 Nov; 156(3):291-8. PubMed ID: 3252557
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
Hanew K; Sasaki A; Sato S; Goh M; Yoshinaga K
J Clin Endocrinol Metab; 1987 Feb; 64(2):255-60. PubMed ID: 3793848
[TBL] [Abstract][Full Text] [Related]
8. Role of dopaminergic receptors in the regulation of growth hormone secretion.
Müller EE; Liuzzi A; Cocchi D; Panerai AE; Oppizzi G; Lacatelli V; Mantegazza P; Silvestrini F; Chiodini PG
Adv Biochem Psychopharmacol; 1977; 16():127-38. PubMed ID: 142419
[No Abstract] [Full Text] [Related]
9. Differential effects of L-dopa and apomorphine on glucagon secretion in man: evidence against central dopaminergic stimulation of glucagon.
Lorenzi M; Tsalikian E; Bohannon NV; Gerich JE; Karam JH; Forsham PH
J Clin Endocrinol Metab; 1977 Dec; 45(6):1154-8. PubMed ID: 591612
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea.
Chalmers RJ; Johnson RH; Keogh HJ; Nanda RN
J Neurol Neurosurg Psychiatry; 1978 Feb; 41(2):135-9. PubMed ID: 24678
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone abnormalities in Huntington's chorea: effect of L-dopa administration.
Podolsky S; Leopold NA
J Clin Endocrinol Metab; 1974 Jul; 39(1):36-9. PubMed ID: 4276011
[No Abstract] [Full Text] [Related]
12. Neuroendocrine aspects in monitoring of dopaminergic drugs in man.
Hietala J; Koulu M; Scheinin M; Syvälahti E
Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):451-4. PubMed ID: 3935892
[TBL] [Abstract][Full Text] [Related]
13. Plasma growth hormone and prolactin response to dopaminergic GABAmimetic and cholinergic stimulation in Huntington's disease.
Durso R; Tamminga CA; Denaro A; Ruggeri S; Chase TN
Neurology; 1983 Sep; 33(9):1229-32. PubMed ID: 6225034
[TBL] [Abstract][Full Text] [Related]
14. Apomorphine hydrochloride-induced improvement in Huntington's chorea: stimulation of dopamine receptor.
Corsini GU; Onali P; Masala C; Cianchetti C; Mangoni A; Gessa G
Arch Neurol; 1978 Jan; 35(1):27-30. PubMed ID: 145840
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrinologic findings in patients with untreated Huntington's chorea.
Caraceni TA; Parati EA; Giovannini PM; Grassi MP; Scigliano G; Carella F; Müller EE
Arch Neurol; 1984 May; 41(5):516-20. PubMed ID: 6232913
[TBL] [Abstract][Full Text] [Related]
16. Cholinergic receptor control mechanisms for L-dopa, apomorphine, and clonidine-induced growth hormone secretion in man.
Delitala G; Maioli M; Pacifico A; Brianda S; Palermo M; Mannelli M
J Clin Endocrinol Metab; 1983 Dec; 57(6):1145-9. PubMed ID: 6688812
[TBL] [Abstract][Full Text] [Related]
17. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
Huseman CA; Hassing JM
J Clin Endocrinol Metab; 1984 Mar; 58(3):419-25. PubMed ID: 6420440
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic stimulation and inhibition of growth hormone secretion in normal man: studies of the pharmacologic specificity.
Bansal SA; Lee LA; Woolf PD
J Clin Endocrinol Metab; 1981 Dec; 53(6):1273-7. PubMed ID: 7028777
[TBL] [Abstract][Full Text] [Related]
19. Role of dopamine in the regulation of growth hormone secretion: dopamine and bromocriptine augment growth hormone (GH)-releasing hormone-stimulated GH secretion in normal man.
Vance ML; Kaiser DL; Frohman LA; Rivier J; Vale WW; Thorner MO
J Clin Endocrinol Metab; 1987 Jun; 64(6):1136-41. PubMed ID: 3553220
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effect of apomorphine and L-DOPA on serum growth hormone levels in normal men.
Lal S; Martin JB; De la Vega CE; Friesen HG
Clin Endocrinol (Oxf); 1975 May; 4(3):277-85. PubMed ID: 1149303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
